OTCMKTS:ACUR Acura Pharmaceuticals (ACUR) Stock Price, News & Analysis → Tiny, One-Half Inch Pellet the Key to INFINITE Energy? (From Eagle Publishing) (Ad) Free ACUR Stock Alerts $0.03 0.00 (0.00%) (As of 06/13/2024 ET) Add Compare Share Share Today's Range$0.03▼$0.0350-Day Range$0.00▼$0.0352-Week Range$0.00▼$0.05VolumeN/AAverage Volume811 shsMarket Capitalization$1.82 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get Acura Pharmaceuticals alerts: Email Address Ad The Oxford ClubYour "AI Income Playbook" Awaits...Today, he wants to give you his "AI Income Playbook"... FREE of charge! Inside, you'll discover Marc's favorite AI dividend stocks... Complete with their names, ticker symbols, and full breakdown of their massive income potential.Click here now to claim your FREE copy of Marc's AI playbook. About Acura Pharmaceuticals Stock (OTCMKTS:ACUR)Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC.Read More ACUR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ACUR Stock News HeadlinesJune 5, 2024 | americanbankingnews.comAcura Pharmaceuticals (OTCMKTS:ACUR) Share Price Crosses Above Two Hundred Day Moving Average of $0.00May 27, 2024 | msn.comStocks To Watch, Shares in News: LIC, Lumax Auto, NMDC, IRCTC, NBCC, Yes Bank, ICICI Bank and moreMay 2, 2024 | yahoo.comJurors in Trump hush money trial hear recording of a call to buy affair story, AP ExplainsMay 2, 2024 | yahoo.comLIV Golf Houston 2024: Patrick Reed | CW39 HOUSTONMay 2, 2024 | yahoo.comMilwaukee Public Schools board director Aisha Carr announces mid-term resignationFebruary 28, 2024 | benzinga.comAcura Pharmaceuticals Stock (OTC:ACUR), Insider Trading ActivityFebruary 10, 2024 | yahoo.comRobert Kraft's foundation wants people to "stand up to hate" with Super Bowl adFebruary 5, 2024 | msn.comAmerican Honda reports 10.3% Y/Y sales growth in January amid a sequential declineJanuary 13, 2024 | morningstar.comAcura Pharmaceuticals Inc ACURNovember 20, 2023 | yahoo.comCumberland man jailed in alleged death threat against district court judgeSeptember 26, 2023 | news.yahoo.comMiami man distributed over $16 million of adulterated HIV drugs given to U.S. patientsAugust 24, 2023 | finance.yahoo.comAcura Pharmaceuticals, Inc. (ACUR)August 12, 2023 | forbes.comAcura Extended Warranty Review: Everything You Need To KnowJune 30, 2023 | au.finance.yahoo.comACUR - Acura Pharmaceuticals, Inc.May 31, 2023 | msn.comGot $1,000? 2 Amazing Growth Stocks That Could Help You Retire RicherMay 3, 2023 | marketwatch.comExploring the Growth Potential of the Opioid Drugs Market till 2031April 27, 2023 | marketwatch.comAzilsartan Medoxomil API Market Forecast to 2030April 22, 2023 | thestreet.com4 Stocks Under $10 Moving HigherApril 9, 2023 | benzinga.comGlobal Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2023: One-Stop Source for Providing Real-Deal Information on Hundreds of TransactionsApril 9, 2023 | marketwatch.comOpioid Drugs Market Sales By 2030March 29, 2023 | marketwatch.comCalming and Sleeping Market Outlook and Forecast till 2028March 13, 2023 | thestreet.comAcura Stock Soars (ACUR)February 17, 2023 | marketwatch.comOpioid Drugs Market Forcast 2023 To 2028 : In-depth Research Analysis with Top Countries DataFebruary 13, 2023 | marketwatch.comAzilsartan Medoxomil API Market 2023-2029 Global Forecast with Top Key Players such as: Takeda, Lupin, Acura Labs, Metrochem APIFebruary 8, 2023 | marketwatch.comOpioid Drugs Market Global Demand, Opportunities, Trends, Analysis and Forecast to 2028See More Headlines Receive ACUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acura Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2020Today6/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:ACUR Previous SymbolNASDAQ:ACUR CUSIP00509L70 CIK786947 Webwww.acurapharm.com Phone(847) 705-7709Fax847-705-5399Employees9Year Founded1935Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.56 million Price / Sales1.17 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares66,349,000Free Float52,947,000Market Cap$1.82 million OptionableNot Optionable Beta1.05 Social Links These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Robert B. Jones (Age 65)CEO, President & Director Comp: $150kMr. Peter A. Clemens (Age 71)Senior VP, CFO & Secretary Comp: $200kMr. Robert A. Seiser CPA (Age 60)Ph.D., VP, Treasurer & Corporate Controller Comp: $210.2kKey CompetitorsEli Lilly and CompanyNYSE:LLYJohnson & JohnsonNYSE:JNJMerck & Co., Inc.NYSE:MRKAbbVieNYSE:ABBVPfizerNYSE:PFEView All Competitors ACUR Stock Analysis - Frequently Asked Questions How have ACUR shares performed in 2024? Acura Pharmaceuticals' stock was trading at $0.0001 at the beginning of 2024. Since then, ACUR stock has increased by 27,400.0% and is now trading at $0.0275. View the best growth stocks for 2024 here. How were Acura Pharmaceuticals' earnings last quarter? Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) released its earnings results on Friday, February, 28th. The specialty pharmaceutical company reported $0.00 earnings per share (EPS) for the quarter. The specialty pharmaceutical company had revenue of $1.32 million for the quarter. What other stocks do shareholders of Acura Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Acura Pharmaceuticals investors own include Denali Therapeutics (DNLI), Adamis Pharmaceuticals (ADMP), Ekso Bionics (EKSO), VIVUS (VVUS), Fulcrum Therapeutics (FULC), (GBSN) (GBSN), Trevena (TRVN), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA) and Advanced Micro Devices (AMD). How do I buy shares of Acura Pharmaceuticals? Shares of ACUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does Acura Pharmaceuticals have any subsidiaries? The following companies are subsidiares of Acura Pharmaceuticals: Acura Pharmaceutical Technologies Inc..Read More This page (OTCMKTS:ACUR) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more poten...Stansberry Research | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acura Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acura Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.